Correlation Between ADMA Biologics and Affimed NV
Can any of the company-specific risk be diversified away by investing in both ADMA Biologics and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADMA Biologics and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADMA Biologics and Affimed NV, you can compare the effects of market volatilities on ADMA Biologics and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADMA Biologics with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADMA Biologics and Affimed NV.
Diversification Opportunities for ADMA Biologics and Affimed NV
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ADMA and Affimed is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding ADMA Biologics and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and ADMA Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADMA Biologics are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of ADMA Biologics i.e., ADMA Biologics and Affimed NV go up and down completely randomly.
Pair Corralation between ADMA Biologics and Affimed NV
Given the investment horizon of 90 days ADMA Biologics is expected to generate 0.61 times more return on investment than Affimed NV. However, ADMA Biologics is 1.65 times less risky than Affimed NV. It trades about 0.13 of its potential returns per unit of risk. Affimed NV is currently generating about -0.02 per unit of risk. If you would invest 351.00 in ADMA Biologics on August 31, 2024 and sell it today you would earn a total of 1,832 from holding ADMA Biologics or generate 521.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ADMA Biologics vs. Affimed NV
Performance |
| Timeline |
| ADMA Biologics |
| Affimed NV |
ADMA Biologics and Affimed NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ADMA Biologics and Affimed NV
The main advantage of trading using opposite ADMA Biologics and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADMA Biologics position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.| ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
| Affimed NV vs. Pieris Pharmaceuticals | Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |